Nicotinamide adenine dinucleotide (
NAD(+) ) not only transfers electrons in mitochondrial respiration, but also acts as an indispensable cosubstrate for
Sirt1, the class III
histone/nonhistone deacetylase. However,
NAD(+) is depleted in
myocardial ischemia/reperfusion (IR) injury. The objective of this study was to investigate the role of exogenous
NAD(+) supplementation in
hypoxia/reoxygenation (HR)-stressed H9c2 cardiac myoblasts. Firstly, the effects of distinct treating time points and doses of
NAD(+) supplementation on the viability of HR-stressed H9c2 cells were detected. Secondly, intracellular
NAD(+) levels in HR-stressed H9c2 cells at various extracellular
NAD(+) concentrations were determined. Thirdly, the role of
NAD(+) supplementation in HR-induced cell apoptosis and its relevance to
Sirtuin 1-p53 pathway were investigated. Exogenous
NAD(+) supplementation elevated intracellular
NAD(+) level and reduced HR-induced cell death in both time- and concentration-dependent manners. It appeared that
NAD(+) supplementation exerted the greatest protection when extracellular concentration ranged from 500 to 1000 μm and when
NAD(+) was added immediately after reoxygenation began.
NAD(+) replenishment restored
Sirt1 activity, reduced the acetylation level of p53 (Lys373 & 382), and attenuated cell apoptosis in HR-stressed H9c2 cells, whereas inhibition of
Sirt1 activity alleviated the effects of
NAD(+) replenishment. These results indicated that exogenous
NAD(+) supplementation attenuated HR-induced cell apoptosis, which was at least partly mediated by restoring
Sirt1 activity and subsequently inhibiting p53 activity via deacetylating p53 at
lysine 373 and 382.